Clinical Trial Update: Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients [Phase 2]

View source ↗

Summary

Phase 2a study of AR882, alone and with febuxostat or allopurinol, in gout patients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• AR882

Snippet

Sponsor: Arthrosi Therapeutics | Conditions: Gout Patients | Phase 2 | Status: COMPLETED